Philadelphia-based Penn Medicine has extended the appointment of CEO Kevin Mahoney through June 2031.
Mr. Mahoney has led the University of Pennsylvania Health System since July 2019, a health system spokesperson said in a June 9 statement shared with Becker’s. He has advanced Penn Medicine’s strategic direction by expanding access points, building a sustainable workforce pipeline and advocating for safer care environments for team members, the spokesperson said.
Mr. Mahoney said in a statement shared with Becker’s that it has been a privilege to serve the Penn Medicine mission for 30 years.
“Penn Medicine is an extraordinary institution, defined by the talent and commitment of its people,” Mr. Mahoney said. “Our clinicians and scientists are turning new ideas into care that improves lives today and sets the direction for what medicine can become. I’m profoundly grateful to be part of this community.”
Mr. Mahoney joined the system in 1996 and previously served as executive vice president and chief administrative officer.
Penn Medicine includes the University of Pennsylvania Health System and the Raymond and Ruth Perelman School of Medicine in Philadelphia.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.